Comparison of the differences between elica and elica m and their uses is a medication that combines the potent anti-inflammatory properties of mometasone furoate with the antifungal action of miconazole nitrate in Elica M. Mometasone furoate, a synthetic corticosteroid, works by inhibiting multiple inflammatory cytokines, thereby reducing the immune response that leads to redness, swelling, and itching associated with skin conditions. Miconazole nitrate, on the other hand, disrupts fungal cell membrane integrity and inhibits fungal growth through the interference with ergosterol synthesis, effectively treating fungal infections. Together, these components provide a dual action that not only alleviates inflammation but also targets and eliminates fungal pathogens, making Elica M particularly suitable for mixed infections involving both inflammation and fungal elements.
Indications and Uses of comparison of the differences between elica and elica m and their uses
- Inflammatory skin disorders such as eczema and dermatitis
- Allergic reactions causing skin irritation
- Superficial fungal infections in conjunction with inflammation
- Redness and itching of the skin
Side Effects of comparison of the differences between elica and elica m and their uses
- Skin irritation or burning sensation at the application site
- Dryness or peeling of the skin
- Allergic reactions including rash or itching
- Secondary infections due to altered skin barrier
Storage and Handling
Store at room temperature, away from direct sunlight and moisture. Keep out of reach of children and do not freeze.
Patient Advice and Precautions
Ensure to apply only to the affected areas and avoid contact with eyes. Consult a healthcare professional if symptoms persist or worsen. Discontinue use if severe irritation occurs and seek medical attention.
Scientific Degree: pharmacist
Country: Egypt
Clinical Pharmacist | Medical & Pharmaceutical Content Writer & Reviewer
A licensed Egyptian pharmacist registered with the Egyptian Pharmacists Syndicate, holding a Bachelor of Pharmaceutical Sciences (B.Pharm.) from the Faculty of Pharmacy, Cairo University in Pharmaceutical Chemistry. She possesses extensive hands-on experience in community pharmacy practice and clinical patient education, specializing in pharmacokinetics, drug-drug interactions, and evidence-based dosing guidelines for both adults and pediatrics.
Dr. Nada serves as a medical writer and reviewer at Rosheta, dedicated to simplifying complex pharmacological data for patients while delivering accurate, up-to-date clinical insights rooted in approved prescribing information and official regulatory standards, including the Egyptian Drug Authority (EDA) and the U.S. FDA.
Published Date: 24 April 2025
you should ask your doctor before taking this medicine